Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Restless Leg Syndrome and Night Terrors01:27

Restless Leg Syndrome and Night Terrors

271
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
271
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

42
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
42
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

53
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
53
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

498
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
498
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

404
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
404
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

436
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
436

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Updated Algorithm for the Management of Restless Legs Syndrome.

Mayo Clinic proceedings·2026
Same author

Neurostimulation for restless legs syndrome: A systematic review and meta-analysis.

Sleep medicine reviews·2026
Same author

Consensus Roadmap on Periodic Leg Movements during Sleep (PLMS): Outcomes of the International PLMS Taskforce.

Sleep·2026
Same author

Pharmacologic treatment data from chronic insomnia studies and the application to individuals with acute insomnia, a narrative review.

Sleep medicine reviews·2026
Same author

Restless Legs Syndrome: A Review.

JAMA·2026
Same author

Effectiveness and dose stability of opioids in patients with restless leg syndrome: 5-year findings from the National Restless Legs Syndrome Opioid Registry.

Sleep·2026

Related Experiment Video

Updated: Sep 24, 2025

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.4K

How effective are treatment guidelines for augmented RLS?

Jonathan Yeung Laiwah1, John W Winkelman2

  • 1Rockyview General Hospital, Calgary, AB, Canada.

Sleep
|May 9, 2022
PubMed
Summary
This summary is machine-generated.

Current treatment guidelines for restless legs syndrome (RLS) augmentation are effective. Switching from dopamine agonists (DAs) to alpha-2-delta ligands (A2D) or opioids improved symptoms in most patients.

Keywords:
RLSaugmentationdopamine agonistgabapentinopioidrestless legs syndrome

More Related Videos

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

932
Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

2.9K

Related Experiment Videos

Last Updated: Sep 24, 2025

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.4K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

932
Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

2.9K

Area of Science:

  • Neurology
  • Pharmacology
  • Sleep Medicine

Background:

  • Restless Legs Syndrome (RLS) augmentation can occur with dopamine agonist (DA) therapy.
  • Current guidelines suggest cross-titration to alpha-2-delta ligands (A2D) and/or opioids for RLS augmentation.
  • Effectiveness of these guidelines in real-world patient populations requires assessment.

Purpose of the Study:

  • To evaluate the effectiveness of current treatment guidelines for RLS augmentation in patients receiving DAs.
  • To assess the outcomes of cross-titrating to A2D ligands and/or opioids.

Main Methods:

  • Retrospective analysis of 63 patients with augmented RLS on DAs, followed for over 5 months.
  • Extracted clinical information from initial consultations and subsequent visits.
  • Assessed patient outcomes using Clinical Global Impression-Severity (CGI-S) and Clinical Global Impression-Improvement (CGI-I) scores.

Main Results:

  • 78% of patients were classified as Responders (significantly improved) after switching treatments.
  • Responders were more likely to discontinue DAs and had higher mean opioid doses.
  • Patients with more severe baseline RLS, insomnia, and daytime sleepiness showed better response.

Conclusions:

  • Guideline-based management, including cross-titration from DAs, is effective for most patients experiencing RLS augmentation.
  • This strategy can lead to significant symptom improvement and reduced reliance on DAs.